Measure
2.7.1.3.1. Arranging an analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of statistical, economic, and other data, as well as the relevant proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures in question
Measure status:
Actual execution date:
31.05.2023
The measure is aimed at achieving ESR:
2.7.1.3. The specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic are established in such a way as to prevent corruption risks
Problem solving:
2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications
Deadlines:
Responsible implementors (authorities):
National Agency on Corruption Prevention
Sources of funding:
state budget
Volumes of financing (thousand UAH):
within the established budget allocations for the relevant year
Performance indicator:
The analytical study has been conducted and a report on its findings has been published.
Implementing status
Progress/Result of implementation:
The Ministry of Health of Ukraine has prepared an analytical report on the assessment of corruption risks during the procurement of medicines and medical devices caused by or carried out during the pandemic in pursuance of the measure provided for in clause 2.7.1.3.1 of the State Anti-Corruption Program for the period 2023–2025.